Intrathecal Pemetrexed for Leptomeningeal Metastasis From Lung Adenocarcinoma That Progressed After Osimertinib.
Clinical trial NCT06296745 · RECRUITING
Trial details
- NCT number
- NCT06296745
- Sponsor
- Guangzhou Medical University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-01
- Primary completion
- 2026-01-20
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.